Loading...
*  Percutaneous transluminal coronary angioplasty | definition of percutaneous transluminal coronary angioplasty by Medical...
Paclitaxel- and sirolimus-eluting stents further reduce the risk of restenosis.. percutaneous transluminal coronary angioplasty ... Product categories covered include drug-eluting coronary stents, bare-metal coronary stents, percutaneous transluminal coronary ... Insertion of a stainless steel stent at the time of balloon angioplasty to maintain arterial patency has improved initial ... stents, and atherectomy as means of increasing blood flow through native coronary arteries.. percutaneous transluminal coronary ...
  https://medical-dictionary.thefreedictionary.com/percutaneous+transluminal+coronary+angioplasty
*  Cordis Announces Discontinuation of NEVOâ„¢ Sirolimus-Eluting Coronary Stent
... Wed, 06/15/2011 - 6:33am Comments by Bio-Medicine ... The company will also stop the manufacture of CYPHER® and CYPHER SELECT® Plus Sirolimus-Eluting Coronary Stents by the end of ... Sirolimus-Eluting Coronary Stent in order to focus on other cardiovascular therapies where significant patient need exists. ... bare metal and drug-eluting stents, carotid stenting, and treatment of peripheral vascular disease and arrhythmias. These ...
  https://www.mdtmag.com/news/2011/06/cordis-announces-discontinuation-nevo%C3%A2%E2%80%9E%C2%A2-sirolimus-eluting-coronary-stent
*  Randomized Study Comparing Endeavor With Cypher Stents (PROTECT) - Full Text View - ClinicalTrials.gov
Sirolimus-eluting Coronary Stent, Cordis Cypher Select® Sirolimus-eluting Coronary Stent or next generation model ... Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent ... Endeavour zotarolimus-eluting stent reduces stent thrombosis and improves clinical outcomes compared with cypher sirolimus- ... Sirolimus-eluting Coronary Stent in a patient population requiring stent implantation.. To assess the safety and efficacy in ...
  https://clinicaltrials.gov/ct2/show/NCT00476957?term=heart+attack&lup_s=04%2F22%2F2013&lup_d=14&show_rss=Y&sel_rss=mod14
*  Antiplatelet Therapy and Stent Thrombosis After Sirolimus-Eluting Stent Implantation | Circulation
Antiplatelet Therapy and Stent Thrombosis After Sirolimus-Eluting Stent Implantation. Takeshi Kimura, Takeshi Morimoto, ... Antiplatelet Therapy and Stent Thrombosis After Sirolimus-Eluting Stent Implantation. Takeshi Kimura, Takeshi Morimoto, ... Antiplatelet Therapy and Stent Thrombosis After Sirolimus-Eluting Stent Implantation. Takeshi Kimura, Takeshi Morimoto, ... Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data ...
  http://circ.ahajournals.org/content/119/7/987
*  Antiplatelet Therapy and Stent Thrombosis After Sirolimus-Eluting Stent Implantation | Circulation
Antiplatelet Therapy and Stent Thrombosis After Sirolimus-Eluting Stent Implantation. Takeshi Kimura, Takeshi Morimoto, ... Antiplatelet Therapy and Stent Thrombosis After Sirolimus-Eluting Stent Implantation. Takeshi Kimura, Takeshi Morimoto, ... Antiplatelet Therapy and Stent Thrombosis After Sirolimus-Eluting Stent Implantation. Takeshi Kimura, Takeshi Morimoto, ...
  http://circ.ahajournals.org/content/early/2009/02/09/CIRCULATIONAHA.108.808311
*  Randomized Comparison of Everolimus-Eluting Stent vs Sirolimus-Eluting Stent in Patients With DIABETES Mellitus
... clinicaltrials.gov The purpose of this study is to establish the safety and effectiveness of coronary stenting with the ... Home » Topics » Stent » Research » Randomized Comparison of Everolimus-Eluting Stent vs Sirolimus-Eluting Stent in Patients ... stent compared to the Sirolimus-Eluting stent in the treatment of de novo coronary stenosis in patients with diabetic patients. ... Randomized Comparison of Everolimus-Eluting Stent vs Sirolimus-Eluting Stent in Patients With DIABETES Mellitus. 2014-08-27 03: ...
  https://www.bioportfolio.com/resources/trial/71679/Randomized-Comparison-of-Everolimus-Eluting-Stent-vs-Sirolimus-Eluting-Stent-in-Patients.html
*  Sirolimus Eluting Stenting in Acute Myocardial Infarction - Full Text View - ClinicalTrials.gov
Randomized Study Of Sirolimus Eluting Stent Vs Conventional Stent In Acute Myocardial Infarction Acronym SESAMI. ... Randomized trial of Sirolimus-Eluting Stent Versus Bare-Metal Stent in Acute Myocardial Infarction (SESAMI). J Am Coll Cardiol ... Sirolimus Eluting Stenting in Acute Myocardial Infarction. The safety and scientific validity of this study is the ... The incidence of stent restenosis in the setting of primary angioplasty is particularly high, reaching a rate of 27% In the ...
  https://clinicaltrials.gov/ct2/show/NCT00288210
*  Repeated occurrence of slow flow phenomenon during and late after sirolimus-eluting stent implantation | SpringerLink
Under these conditions, two overlapping sirolimus-eluting stent (SES) implantation in this lesion resulted in slow flow which ... Otsuka Y, Nakamura M, Kokubu N, Tonooka A, Inoue K, Higami T (2012) Diffuse in-stent restenosis of CYPHER® stent due to ... Repeated occurrence of slow flow phenomenon during and late after sirolimus-eluting stent implantation. ... Inoue K (2010) Drug-eluting stents are not indicated for patients with acute coronary syndrome -should drug-eluting stents be ...
  https://link.springer.com/article/10.1007%2Fs00380-014-0477-8
*  Sirolimus-Eluting Stents for Chronic Total Coronary Occlusions - Full Text View - ClinicalTrials.gov
drug-eluting stent. chronic total occlusion. sirolimus-eluting stent. zotarolimus-eluting stent. QCA. ... Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003 Oct 2 ... Whether sirolimus-eluting stents are superior to bare metal stents in CTO is unknown. In this prospective randomized trial, ... Sirolimus-Eluting Stents for Chronic Total Coronary Occlusions: A Randomized Comparison of Bare Metal Stent Implantation With ...
  https://clinicaltrials.gov/ct2/show/NCT00258596
*  Direct Stenting Using the Sirolimus-Eluting Stent - American College of Cardiology
Direct Stenting Using the Sirolimus-Eluting Stent - DIRECT. May 07, 2004 Share via: ... The SIRIUS-DIRECT trial: a multi-center study of direct stenting using the sirolimus-eluting stent in patients with de novo ... Patients were enrolled at 16 US sites from April-June 2003 and received sirolimus-eluting stents using direct stenting. The ... Keywords: Coronary Artery Disease, Myocardial Infarction, Pyridinolcarbamate, Thrombosis, Drug-Eluting Stents, Sirolimus, ...
  http://www.acc.org/latest-in-cardiology/clinical-trials/2013/05/23/10/50/direct
*  Comparison of Everolimus-Eluting Stent vs Sirolimus-Eluting Stent in Patients With DIABETES Mellitus - Full Text View -...
Comparison of Everolimus-Eluting Stent vs Sirolimus-Eluting Stent in Patients With DIABETES Mellitus (ESSENCE-DM). The safety ... Randomized Comparison of Everolimus- Eluting Stent Versus Sirolimus-Eluting Stent Implantation for De Novo Coronary Artery ... Eluting stent compared to the Sirolimus-Eluting stent in the treatment of de novo coronary stenosis in patients with diabetic ... Stent thrombosis by definition of Academic Research Consortium (ARC) [ Time Frame: 12 months ]. *Stent thrombosis by definition ...
  https://clinicaltrials.gov/ct2/show/NCT00997763
*  Abstract 2159: Medial Necrosis Due to Sirolimus-Eluting Stent Implantation in Human Coronary Arteries | Circulation
Background: Sirolimus-eluting stents (SES) have been proven to reduce the rates of restenosis by a striking inhibition of ... Abstract 2159: Medial Necrosis Due to Sirolimus-Eluting Stent Implantation in Human Coronary Arteries. Katsumi Inoue, Kazuaki ... Abstract 2159: Medial Necrosis Due to Sirolimus-Eluting Stent Implantation in Human Coronary Arteries ... Abstract 2159: Medial Necrosis Due to Sirolimus-Eluting Stent Implantation in Human Coronary Arteries ...
  http://circ.ahajournals.org/content/116/Suppl_16/II_468.3
*  Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. - PubMed - NCBI
Sirolimus-eluting coronary stents. [N Engl J Med. 2004]. *Sirolimus for the prevention of in-stent restenosis in a coronary ... Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery.. Moses JW1, Leon MB, ... We conducted a randomized, double-blind trial comparing a sirolimus-eluting stent with a standard stent in 1058 patients at 53 ... 4.1 percent in the sirolimus-stent group, P,0.001). The frequency of neointimal hyperplasia within the stent was also decreased ...
  https://www.ncbi.nlm.nih.gov/pubmed/14523139?access_num=14523139&link_type=MED&dopt=Abstract
*  Sirolimus Stents Exacerbate Endothelial Injury after MI | DAIC
October 17, 2007 - Compared to bare metal stents, in patients with acute myocardial infarction, sirolimus-eluting stent (SES) ... News , Stents Drug Eluting , May 31, 2018 Titanium-Nitride-Oxide Stent Superior to Bioabsorbable Drug-Carrier DES in Acute ... Technology , Stents Drug Eluting , December 13, 2017 Cordis and Medinol Announce FDA Approval of EluNIR Drug-Eluting Stent ... News , Stents Drug Eluting , January 25, 2018 Biotronik Symposium Highlights Differing Roles of Drug-Eluting Stents and ...
  https://www.dicardiology.com/content/sirolimus-stents-exacerbate-endothelial-injury-after-mi
*  Sirolimus-eluting Stents With Biodegradable Polymer Versus an Everolimus-eluting Stents - No Study Results Posted -...
Sirolimus-eluting Stents With Biodegradable Polymer Versus an Everolimus-eluting Stents. The safety and scientific validity of ... Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents for primary percutaneous ... Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent Versus Durable-Polymer Everolimus-Eluting Stent for Percutaneous ... Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous ...
  https://clinicaltrials.gov/ct2/show/results/NCT01443104?show_rss=Y&sel_rss=mod14
*  Sirolimus-Eluting Stent vs. Intravascular Brachytherapy in In-Stent Restenotic Coronary Artery Lesions(SISR) - Full Text View -...
Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial ... Device: Sirolimus-Eluting Bx Velocity® Balloon Expandable Stent Sirolimus-Eluting Bx Velocity® Balloon Expandable Stent ... Sirolimus-Eluting Stent vs. Intravascular Brachytherapy in In-Stent Restenotic Coronary Artery Lesions(SISR). The safety and ... In-Stent Restenosis Device: Sirolimus-Eluting Bx Velocity® Balloon Expandable Stent Procedure: Brachytherapy Phase 3 ...
  https://clinicaltrials.gov/ct2/show/NCT00231257
*  First-in-Human Evaluation of a Bioabsorbable Polymer-Coated Sirolimus-Eluting Stent | JACC: Cardiovascular Interventions
absorbable polymer-coated, sirolimus-eluting stent(s). BMS. bare-metal stent(s). CI. confidence interval. DAPT. dual ... sirolimus-eluting stent. ST. stent thrombosis. TLR. target lesion revascularization. TVR. target vessel revascularization. ... The stent is coated with antiproliferative crystalline sirolimus within a fully AP and mounted on a stent delivery system. The ... 2002) A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med ...
  http://interventions.onlinejacc.org/content/6/10/1026
*  Preliminary Evaluation of Clinical and Angiographic Outcomes with Biodegradable Polymer Coated Sirolimus-Eluting Stent in De...
Preliminary Evaluation of Clinical and Angiographic Outcomes with Biodegradable Polymer Coated Sirolimus-Eluting Stent in De ... This study provides preliminary evidence for the feasibility, safety, and efficacy of the Supraflex sirolimus-eluting stent. ... and efficacy of the Supraflex sirolimus-eluting stent (SES) implantation, in de novo coronary artery disease, using clinical ... Total of 66 lesions, analyzed by offline QCA, showed good scaffolding of the target vessel with in-stent late lumen loss at 9 ...
  https://www.hindawi.com/journals/scientifica/2016/9324279/abs/
*  Right coronary artery 'diverticulosis' 4 years after sirolimus-eluting stent implantation associated with very late stent...
Right coronary artery 'diverticulosis' 4 years after sirolimus-eluting stent implantation associated with very late stent ... Right coronary artery 'diverticulosis' 4 years after sirolimus-eluting stent implantation associated with very late stent ...
  http://heart.bmj.com/content/99/21/1627.alerts
*  Sirolimus-Eluting Stent for the Treatment of In-Stent Restenosis. A Quantitative Coronary Angiography and Three-Dimensional...
Sirolimus-Eluting Stent for the Treatment of In-Stent Restenosis. A Quantitative Coronary Angiography and Three-Dimensional ... Sirolimus-Eluting Stent for the Treatment of In-Stent Restenosis. A Quantitative Coronary Angiography and Three-Dimensional ... Sirolimus-Eluting Stent for the Treatment of In-Stent Restenosis. A Quantitative Coronary Angiography and Three-Dimensional ... Sirolimus-Eluting Stent for the Treatment of In-Stent Restenosis. A Quantitative Coronary Angiography and Three-Dimensional ...
  http://circ.ahajournals.org/content/early/2002/12/02/01.CIR.0000047063.22006.41
*  CYPHER® Sirolimus-eluting Coronary Stent benefits from clinical success, worldwide growth in 2005 | EurekAlert! Science News
Sirolimus-eluting Coronary Stent compared with the Taxus stent in the areas of late loss, re-treatment (total lesion ... Stent vs. 29 percent for Taxus stent, p=0.05) and undergo TLR (4 percent for CYPHER® Stent vs. 13 percent for Taxus stent, p= ... Stent was associated with fewer blood clots at the stent site (stent thromboses) compared to the Taxus stent. Other trials ... Sirolimus-eluting Coronary Stent, which is the first next generation drug-eluting stent, was launched in Europe, Asia Pacific, ...
  https://www.eurekalert.org/pub_releases/2005-12/epr-csc122105.php
*  Three-Year Outcomes After Sirolimus-Eluting Stent Implantation for Unprotected Left Main Coronary Artery Disease. Insights From...
Three-Year Outcomes After Sirolimus-Eluting Stent Implantation for Unprotected Left Main Coronary Artery Disease. Insights From ... Three-Year Outcomes After Sirolimus-Eluting Stent Implantation for Unprotected Left Main Coronary Artery Disease. Insights From ... Three-Year Outcomes After Sirolimus-Eluting Stent Implantation for Unprotected Left Main Coronary Artery Disease. Insights From ... Three-Year Outcomes After Sirolimus-Eluting Stent Implantation for Unprotected Left Main Coronary Artery Disease. Insights From ...
  http://circ.ahajournals.org/content/early/2009/10/26/CIRCULATIONAHA.109.873349
*  Correlates and Long-Term Outcomes of Angiographically Proven Stent Thrombosis With Sirolimus- and Paclitaxel-Eluting Stents |...
Correlates and Long-Term Outcomes of Angiographically Proven Stent Thrombosis With Sirolimus- and Paclitaxel-Eluting Stents. ... Correlates and Long-Term Outcomes of Angiographically Proven Stent Thrombosis With Sirolimus- and Paclitaxel-Eluting Stents ... Correlates and Long-Term Outcomes of Angiographically Proven Stent Thrombosis With Sirolimus- and Paclitaxel-Eluting Stents ... Correlates and Long-Term Outcomes of Angiographically Proven Stent Thrombosis With Sirolimus- and Paclitaxel-Eluting Stents ...
  http://circ.ahajournals.org/content/early/2006/02/20/CIRCULATIONAHA.105.600155
*  Abstract 2777: Optimal Expansion of the Stent is a Major Contributor to the Neointimal Coverage Following Sirolimus-eluting...
Background: Although sirolimus-eluting stent (SES) has significantly reduced in-stent restenosis by inhibiting neointimal ... Optimal expansion of the stent is a major contributor to the complete neointimal coverage following sirolimus-eluting stent ... Optimal Expansion of the Stent is a Major Contributor to the Neointimal Coverage Following Sirolimus-eluting Stent Implantation ... Optimal Expansion of the Stent is a Major Contributor to the Neointimal Coverage Following Sirolimus-eluting Stent Implantation ...
  http://circ.ahajournals.org/content/116/Suppl_16/II_616.4